A New Frontier in Oncology: Researchers Identify Novel Compounds to Neutralize Lethal Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) has long remained one of the most formidable adversaries in clinical oncology. Characterized by its late diagnosis, aggressive biological behavior, and a notorious resistance to conventional chemotherapy, it…